OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

REGISTERED CHARITY NUMBER: 1195569

Report of the Trustees and

Unaudited Financial Statements for the Year Ended 31 March 2023

for

International Institute For Psychiatric Drug Withdrawal

Willsons Chartered Accountants Carlton House High Street Higham Ferrers Northamptonshire NN10 8BW

International Institute For Psychiatric Drug Withdrawal

Contents of the Financial Statements for the Year Ended 31 March 2023

Page
Report of the Trustees 1 to 8
Independent Examiner's Report 9
Statement of Financial Activities 10
Balance Sheet 11
Notes to the Financial Statements 12 to 14
Detailed Statement of Financial Activities 15

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

The trustees present their report with the financial statements of the charity for the year ended 31 March 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

The aims stated in our governing document are:

Significant activities

This year is the first full reporting year for IIPDW as a UK Charity. IIPDW focused on developing operational stability and strengthening its financial position, while also growing its reach both within the UK and internationally via online conferences, informative events, newsletters, resources on our website and YouTube channel. It has been a year for getting to know the landscape of psychiatric drug withdrawal, and generating ideas for the future of IIPDW.

Public benefit

Our Trustees have paid due regard to the Charity Commission's Guidance on Public Benefit (PB1-3) and all activities have undertaken by IIPDW have been for the public benefit in furthering the stated aims of IIPDW.

Page 1

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

ACHIEVEMENT AND PERFORMANCE

Charitable activities

Network Meetings

IIPDW continued to foster and facilitate an international network of experts in psychiatric drug withdrawal, hosting quarterly Network Meetings online during which Associates of IIPDW connect, share updates from their countries, talk about their work and develop collaborations on projects related to IIPDW's aims.

IIPDW continued to welcome new Associates throughout the year:

Radoslaw Stupak, Poland Cathal Cadogan, Ireland Enric Garcia Torrents, Spain Maeva Musso, France Nicole Lamberson, USA Sandra Jayacodi, UK Mark Sanderson, UK Anando Chatterji, India Shama Parkhe, India Anonymous, New Zealand Golan Krumholz, Israel

Notable discussion in the Network Meetings includes:

-Researchers at UCL and Kings College, London presented on how IIPDW Associates can contribute to an NHS review into alternatives to inpatient care

-Italian researcher Raffaella Pocobello presented a new Guideline for Deprescribing co-created with Drs Giuseppe Tibaldi, Marcello Macario and the Italian network associated with IIPDW, 160 people active in mental health field in Italy. The Guideline is on IIPDW's website.

In July 2022, the Administrator gave a short talk on the history and aims of IIPDW after which Associates discussed the future of IIPDW and how best to achieve these aims.

Online Conferences

May 2022

IIPDW hosted a 2-day online conference in May 2022 with 6 international speakers covering different aspects of Withdrawal from Psychiatric Drugs. 435 people from 34 countries attended across every continent.

The programme was as follows:

Carina Håkansson - Experiences from the Front Line Robert Whitaker - What's wrong with psychiatric drugs? Laura Delano - The reality of withdrawal? Magnus Hald - Drug-free treatment in Norway Joanna Moncrieff - The myth of the chemical cure

After the conference we hosted a Zoom meeting for the audience to connect, reflect on the content of the 2 days and discuss how to have a positive impact in the area of psychiatric drug withdrawal. Over 120 joined this meeting, many posting contact details or requests for collaboration in the chat.

For IIPDW, the discussion was an effective way to hear from attendees about existing work being done all over the world in this field, by people with lived experience, family members, grass-roots organisations, researchers, clinicians and prescribers wanting change. It also generated ideas for future projects to further IIPDW's aims.

Page 2

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees

for the Year Ended 31 March 2023

The recordings were uploaded to our YouTube channel where they've been viewed over 9000 times collectively with significant engagement in the comments.

We also gave out media passes to journalists; coverage of the conference included an article in prominent Swedish newspaper Socialpolitik , 17th May 2022.

Feedback on the conference was overwhelmingly positive. Many called for more events or spoke of a need to reach a wider audience, and praised the speakers for their humanity and empathy. Some framed the conference as part of a wider movement towards making change, celebrating its activism and community-building.

February 2023

Due to the success of May's conference, IIPDW hosted a second online conference in February 2023 entitled Withdrawal from Psychiatric Drugs 2. Speakers included:

Joanna Moncrieff & Mark Horowitz - Chemical Imbalance, what chemical imbalance? Adele Framer, Sarah Tilley & Karen Prellwitz-Hoffmann - How can peer support change healthcare? Mark Sanderson & Sandra Jayacodi - Learning from Lived Experience

Dainius Pūras - Child and Adolescent Mental Health: Reflections on recent global and regional developments Will Hall, Angela Peacock & Anne Guy - Effective Withdrawal Lessons for Therapists

278 people attended this conference from 30 countries across every continent. 22 purchased the top-tier ticket intended for highly paid clinicians and 43 bought the ticket for working people, suggesting the conference is reaching professionals working in roles relating to psychiatric drug withdrawal.

IIPDW gave out 35 free tickets to people personally affected by psychiatric drugs who were unable to afford a ticket, and 2 discounts to people living in the global south.

The conference allowed IIPDW to identify emerging themes, unanswered questions and stakeholder groups relating to psychiatric drug withdrawal. For example, several people asked about the potential role of pharmacists in supporting withdrawal; IIPDW then reached out to a UK pharmacist for future partnership.

Feedback from the conference included:

'I can't tell you how informative and life enhancing the entire conference this afternoon has been, because when my doctor told me I'd have to be on antipsychotics for the rest of my life it just took away every shred of hope I had that things could change, and I was put on them for trauma, and came off them too quickly and then became psychotic and then the cycle occurred. This afternoon has been a true game changer...hearing what I've heard today about tapering and the effect it has on your brain has really been very...I can't tell you what it's meant to me'.

Video on Antidepressant Withdrawal

In March 2022, Board Member Stevie Lewis and IIPDW Associate Mark Horowitz completed a 55-minute video on Antidepressant Withdrawal Syndrome and its Management, with input from Board Members Ruth Cooper and John Read and production by Mind Wick. At the start of the reporting year this was uploaded to our website and YouTube, and has since been viewed 19,803 times (2745 on our website and 16,058 on YouTube).

Online Screenings

The video was first screened online at our conferences in May 2022 and February 2023.

IIPDW then co-hosted a screening of the video on 5th November 2022 with non-profit organisation Mad in America, including a panel discussion of Mark Horowitz, Stevie Lewis, Anders Sørensen and Laura Delano. IIPDW Board Member Swapnil Gupta and Mad in America Board Member Kermit Kole moderated the panel. Collaboration with Mad in America allowed IIPDW to get the video seen by a larger audience across the globe.

248 people attended, many contributing to the chatbox in the Zoom webinar. Comments include:

"Thank you, this was super informative, and I will be sharing this with my patients"

Page 3

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

"Much thanks to panel and organizers and participants. It was very helpful, I support a number of people with diverse relationships to psych meds."

"So nice to see younger people off these drugs. Hope for my son..."

"Just wanted to say thank you for today .....makes me feel more hopeful and less alone"

This webinar has also been viewed 10,000 times on YouTube. Comments include:

"Such incredibly important information. I wonder how this film can be distributed to physicians, especially to pediatricians who seem to increasingly be putting 9 and 10 year olds on these meds!!! I work as a school psychologist and see this as an increasing trend. I am also a psychiatric drug withdrawal survivor. Thank you again for this work!!!"

"God bless all of you for making this video. You are doing God's work in a world of lies and deception. Been on effexor for 16 years with emotional numbness and its no way to live life. The medical establishment has no idea how to get a person off these drugs safely and I'm thankful and hopeful for the future after seeing this video. There is hope for me after all."

"Thank you for putting this out! I've tried to stop Venlafaxine many times. Last time I went from 112.5 mg to 0 mg in one year. After 2 - 3 months without I had a restlessness that can only be described as hell. I thought I was gonna kill myself. What I didnt know was that I need to taper according to your graphics and and I need to go much slower! I'm now tapering 5% off from the current amount and it will maybe take me three years or so."

"Thank you ...we need people like you so much. End the suffering of psychotropic meds...teach the GP's psychiatrist. All they want is prescribe harm"

Translations

IIPDW has worked with volunteers internationally to produce subtitles in different languages for the video Antidepressant Withdrawal Syndrome and its Management . During the reporting year, four new languages were made available to the public:

Dutch (689 views on YouTube) Italian (620 views on YouTube) Norwegian (209 views on YouTube) Swedish (98 views on YouTube)

We also worked with volunteers and Associates to get these videos uploaded on other relevant sites for international audiences. For example, the Netherlandish version was embedded into a dedicated page on Mad in the Netherlands where it's been viewed 200 times.

British Journal of General Practice

The video was featured in an article in the online publication of BJGP Life (18th May 2022), a magazine for UK GPs. For many GPs, this may be the first time they've been exposed to information about safe tapering of antidepressants. The references below the article offered opportunity for further learning.

IIPDW Website

Our website is an effective way to share information about psychiatric drug withdrawal with the public. In April 2022 the IIPDW Board began compiling a list of the most relevant research papers, articles and online resources for patients and professionals interested in psychiatric drug withdrawal. This was uploaded to our website with dedicated pages on antidepressants, antipsychotics, benzodiazepines, international language resources, research, and others.

Page 4

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

Newsletters and Social Media

IIPDW continued to develop its newsletter this year, sending 21 bulletins about publications, developments and events directly relevant to psychiatric drug withdrawal. During the year our mailing list grew from 300 people to over 800 and counting, showing a need for information on this topic.

Scottish Antidepressant Quality Prescribing Guideline

In April 2022 IIPDW has submitted feedback to the draft Antidepressant Quality Prescribing Guide written by the Effective Prescribing and Therapeutics Division of the Scottish Government. This feedback was co-written by IIPDW Associate Dr Mark Horowitz and IIPDW Board Member Stevie Lewis.

All Wales Therapeutic and Toxicology Centre - Polypharmacy Review in Older People

In September 2022 IIPDW submitted to the consultation by the All Wales Therapeutic and Toxicology Centre on the draft 'Polypharmacy review: Guidance for prescribing'. The submission was co-written by IIPDW Associate Dr Mark Horowitz and IIPDW Board Member Stevie Lewis. The IIPDW proposed a re-write of the draft section on Antidepressant deprescribing to meet the NICE Guidelines NG215 and NG222. This proposal was accepted in full by the AWTTC.

Support for Polish Journalist

In January 2023, Polish journalist Beata Pawlikowska was subjected to harassment and death threats following a YouTube video in which she covered recent research on the serotonin hypothesis of depression. A crowd-fundraiser started by a prominent Polish psychiatrist raised over 30,000 złoty to take her to court. IIPDW began authoring a statement in support of Pawlikowska, during which time the criminal case was dropped.

Partnerships & Endorsements

From July 2022 IIPDW endorsed LEAP4PDD.org with a logo on their website. LEAP4PDD is a coalition of people with lived experience in the UK who would like to be involved in setting up NHS services for withdrawal.

From October 2022 IIPDW partnered with the PROTECT Study at Trinity College Dublin which will use a James Lind Alliance Priority Setting Partnership (PSP) to determine the Top 10 priorities (i.e. unanswered questions) for future research on reducing and stopping psychiatric medicines.

Volunteers

IIPDW is grateful to 22 volunteers who gave their time, knowledge and skills for free. These were speakers at our conferences, and translators who carefully edited automated translations of subtitles for our video, 'Antidepressant Withdrawal Syndrome and its Management'.

Page 5

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

FINANCIAL REVIEW

Financial position

April 2022 represented the third operational month of IIPDW's financial activity. This year, IIPDW was able to strengthen both its financial position and operational stability in preparation for furthering its aims.

Principal funding sources

The principle sources of funds were ticket sales from online events and donations.

Online Events

Tickets to our two online conferences were sold via Eventbrite.co.uk and generated a net payment after Eventbrite fees of £11,183 in May 2022 and £6876 in February 2023. IIPDW also received £682.18 from November's online Town Hall event in collaboration with Mad in America.

Donations

Our online donation page took £2110.20 in small donations over the financial year. Donations were boosted by a call-out IIPDW sent out via email to our Associates, via our newsletter and via social media. This also led to a larger donation of £7984 from an anonymous donor in New Zealand.

IIPDW also received two large international donations via bank transfer this year from donors in Belgium (£8403 in December 2022) and Switzerland (£4905 in January 2023).

IIPDW's Chair of Trustees Professor John Read donated £200 on 31st August 2022, this was the proceeds of a 2-hour lecture he gave to the British Psychological Society on Psychiatric Drugs: the role of non-medical mental health professionals (23rd June 2022).

Reserves policy

The trustees aim to maintain free reserves in unrestricted funds at a level which equates to approximately six months of unrestricted charitable expenditure to ensure operations can continue in hard times. At present levels of operations this amounts to £12,000 and we have achieved free reserves of £27,747. Trustees are currently considering IIPDW's wider work in pursuit of its aims, including the possibility and viability of in-person conference.

Principle Risks Facing the Charity

Trustees have considered the major risks to which the charity is exposed and satisfied themselves that procedures are established to manage those risks. This process of monitoring risk is carried out annually in preparation for making a statement to the Charity Commission, and whenever risks arise or evolve.

Review of Internal Financial Controls

The Trustees continue to review internal financial controls with regard to Charity Commission guidance CC8.

In September 2022 IIPDW was the victim of systematic card testing when £365 was donated to us by criminals with the aim of verifying stolen credit card data. This incident was picked up by the Administrator within 24 hours and all fraudulent donations were refunded to cardholders immediately. We sought advice from NCVO and took steps to improve our online donation form to include extra layers of verification, to prevent this recurring.

Page 6

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees for the Year Ended 31 March 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

IIPDW is a Charitable Incorporated Organisation (CIO), using a Foundation Model Constitution as the basis for its Governing Document.

Recruitment and appointment of new trustees

Towards the end of this year, two valued Trustees Kleonike Giannakopoulou and Swapnil Gupta resigned from their roles as they needed to give their time to other commitments in their lives and work.

On 18th January 2023, we advertised a Board Vacancy to all IIPDW Associates by email, and requested a statement from each interested person about their skills, experience and any vision they have for IIPDW.

On 3rd March 2023 Adele Framer was voted in unanimously by the Board as a new Trustee of IIPDW. Adele is the founder in 2011 of an online forum called SurvivingAntidepressants.org which has over 12,000 registrations and over 300,000 monthly page views. She's authored articles in peer-reviewed journals including 'What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications' (Therapeutic Advances in Psychopharmacology, 2021), and contributed to the development of Outro.com.

Upon her appointment, Adele received the Trustee Welcome Pack:

Adele signed the Trustee Declaration and Board Code of Conduct to be kept on file. This process complies with the Terms of our Governing Document 10 (1) and 10 (2).

New Associates

Anyone interested in being an Associate of IIPDW should email us a paragraph about their knowledge and experience relating to psychiatric drug withdrawal, the Board then votes to accept or decline these applications.

Page 7

International Institute For Psychiatric Drug Withdrawal

Report of the Trustees

for the Year Ended 31 March 2023

REFERENCE AND ADMINISTRATIVE DETAILS

Registered Charity number

1195569

Principal address

5 Brayford Square London E1 0SG

Trustees

Dr John Read Chair person Miss Ruth Ellen Cooper Treasurer/Trustee Dr Swapnil Gupta (resigned 20.3.23) Olga Ruth Runciman Kleonike Giannakopoulou (resigned 13.1.23) Mrs Stephanie Lewis Trustee Adele Framer (appointed 3.3.23) Marnie Wedlake (appointed 21.4.23) Dr Josef Witt-Doerring (appointed 2.6.23)

Senior Staff Member: Administrator, Lucy Fernandes

Independent Examiner

Willsons Chartered Accountants Carlton House High Street Higham Ferrers Northamptonshire NN10 8BW

International Institute for Psychiatric Drug Withdrawal (commonly abbreviated to IIPDW). We are a registered UK Institute approved by Companies House.

Approved by order of the board of trustees on 29 January 2024 and signed on its behalf by:

Dr John Read - Trustee

Page 8

Independent Examiner's Report to the Trustees of International Institute For Psychiatric Drug Withdrawal

Independent examiner's report to the trustees of International Institute For Psychiatric Drug Withdrawal

I report to the charity trustees on my examination of the accounts of International Institute For Psychiatric Drug Withdrawal (the Trust) for the year ended 31 March 2023.

Responsibilities and basis of report

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

C Baird FCA

The Institute of Chartered Accountants in England and Wales

Willsons Chartered Accountants Carlton House High Street Higham Ferrers Northamptonshire NN10 8BW

29 January 2024

Page 9

International Institute For Psychiatric Drug Withdrawal

Statement of Financial Activities for the Year Ended 31 March 2023

Period
19.8.21
Year Ended to
31.3.23 31.3.22
Unrestricted Restricted Total Total
fund fund funds funds
Notes £ £ £ £
INCOME AND ENDOWMENTS FROM
Donations and legacies 23,310 - 23,310 5,676
Charitable activities
Charitable activities 18,742 - 18,742 -
Other income 3,250 - 3,250 -
Total 45,302 - 45,302 5,676
EXPENDITURE ON
Charitable activities
Charitable activities 19,236 3,195 22,431 800
Governance costs 1,056 - 1,056 -
Total 20,292 3,195 23,487 800
NET INCOME/(EXPENDITURE) 25,010 (3,195) 21,815 4,876
RECONCILIATION OF FUNDS
Total funds brought forward 1,681 3,195 4,876 -
TOTAL FUNDS CARRIED FORWARD 26,691 - 26,691 4,876

The notes form part of these financial statements

Page 10

International Institute For Psychiatric Drug Withdrawal

Balance Sheet 31 March 2023

31.3.23 31.3.22
Unrestricted Restricted Total Total
fund fund funds funds
Notes £ £ £ £
CURRENT ASSETS
Cash at bank 27,747 - 27,747 4,876
CREDITORS
Amounts falling due within one year 5 (1,056) - (1,056) -
NET CURRENT ASSETS 26,691 - 26,691 4,876
TOTAL ASSETS LESS CURRENT
LIABILITIES 26,691 - 26,691 4,876
NET ASSETS 26,691 - 26,691 4,876
FUNDS 6
Unrestricted funds 26,691 1,681
Restricted funds - 3,195
TOTAL FUNDS 26,691 4,876

The financial statements were approved by the Board of Trustees and authorised for issue on 29 January 2024 and were signed on its behalf by:

Dr John Read - Trustee

The notes form part of these financial statements

Page 11

International Institute For Psychiatric Drug Withdrawal

Notes to the Financial Statements for the Year Ended 31 March 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 March 2023 nor for the period ended 31 March 2022.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 March 2023 nor for the period ended 31 March 2022.

continued...

Page 12

International Institute For Psychiatric Drug Withdrawal

Notes to the Financial Statements - continued for the Year Ended 31 March 2023

3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted Restricted
Total
fund fund funds
£ £ £
INCOME AND ENDOWMENTS FROM
Donations and legacies 2,481 3,195 5,676
EXPENDITURE ON
Charitable activities
Charitable activities 800 - 800
NET INCOME 1,681 3,195 4,876
TOTAL FUNDS CARRIED FORWARD 1,681 3,195 4,876
4. GOVERNANCE COSTS
These comprise the independent examination cost of £1,056.
5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£ £
Other creditors 1,056 -
6. MOVEMENT IN FUNDS
Net
movement At
At 1.4.22 in funds 31.3.23
£ £ £
Unrestricted funds
Charitable activities undertaken directly 1,681 25,010 26,691
Restricted funds
Restricted fund 3,195 (3,195) -
TOTAL FUNDS 4,876 21,815 26,691
Net movement in funds, included in the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
Charitable activities undertaken directly 45,302 (20,292) 25,010
Restricted funds
Restricted fund - (3,195) (3,195)
TOTAL FUNDS 45,302 (23,487) 21,815

continued...

Page 13

International Institute For Psychiatric Drug Withdrawal

Notes to the Financial Statements - continued for the Year Ended 31 March 2023

6. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Net
movement At
in funds 31.3.22
£ £
Unrestricted funds
Charitable activities undertaken directly 1,681 1,681
Restricted funds
Restricted fund 3,195 3,195
TOTAL FUNDS 4,876 4,876

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
Charitable activities undertaken directly 2,481 (800) 1,681
Restricted funds
Restricted fund 3,195 - 3,195
TOTAL FUNDS 5,676 (800) 4,876

7. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 March 2023.

Page 14

International Institute For Psychiatric Drug Withdrawal

Detailed Statement of Financial Activities

for the Year Ended 31 March 2023

Detailed Statement of Financial Activities
for the Year Ended 31 March 2023
Period
19.8.21
Year Ended to
31.3.23 31.3.22
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Donations 23,310 5,676
Charitable activities
Conference ticket sales 18,060 -
Online event sales 682 -
18,742 -
Other income
Sundry income 3,250 -
Total incoming resources 45,302 5,676
EXPENDITURE
Charitable activities
Conference costs 444 -
Sundry costs 3,110 800
Administrator fees 18,877 -
22,431 800
Support costs
Governance costs
Independent examination cost 1,056 -
Total resources expended 23,487 800
Net income 21,815 4,876

This page does not form part of the statutory financial statements

Page 15